1-8 of 8
Cecilia L. Speyer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4039: Riluzole synergizes with paclitaxel to induce apoptosis and inhibit cell growth in triple negative breast cancer

Miriam A. Bukhsh, Cecilia L. Speyer, Waris S. Jafry, Rachel E. Sexton, David Thomas, David Gorki
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4039.
https://doi.org/10.1158/1538-7445.AM2017-4039
Published: 01 July 2017
View article titled, Abstract 4039: Riluzole synergizes with paclitaxel to induce apoptosis and inhibit cell growth in triple negative breast cancer
Journal Articles

PDGFRα and β Play Critical Roles in Mediating Foxq1-Driven Breast Cancer Stemness and Chemoresistance

Fanyan Meng, Cecilia L. Speyer, Bin Zhang, Yongzhong Zhao, Wei Chen, David H. Gorski, Fred R. Miller, Guojun Wu
Journal: Cancer Research
Cancer Res (2015) 75 (3): 584–593.
https://doi.org/10.1158/0008-5472.CAN-13-3029
Published: 01 February 2015
View article titled, PDGFRα and β Play Critical Roles in Mediating Foxq1-Driven Breast Cancer Stemness and Chemoresistance
Open the PDF for PDGFRα and β Play Critical Roles in Mediating Foxq1-Driven Breast Cancer Stemness and Chemoresistance in another window
Includes: Supplementary data
Journal Articles

Abstract 4608: Exploring anti-oncogenic properties of riluzole in breast cancer

Miriam A. Bukhsh, Cecilia L. Speyer, Ali A. Hachem, Mahdy Nassar, Ali A. Assi, David H. Gorski
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4608.
https://doi.org/10.1158/1538-7445.AM2014-4608
Published: 01 October 2014
View article titled, Abstract 4608: Exploring anti-oncogenic properties of riluzole in breast cancer
Journal Articles

Abstract 3895: Metabotropic glutamate receptor-1 as a novel target for the anti-angiogenic treatment of breast cancer.

Cecilia L. Speyer, Ali H. Hachem, Ali Assi, John A. DeVries, David H. Gorski
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3895.
https://doi.org/10.1158/1538-7445.AM2013-3895
Published: 15 April 2013
View article titled, Abstract 3895: Metabotropic glutamate receptor-1 as a novel target for the anti-angiogenic treatment of breast cancer.
Journal Articles

Abstract 1206: Metabotropic glutamate receptor 1 functions as an oncogene in the progression of triple negative breast cancer

Malathi Banda, Cecilia L. Speyer, Larry Tait, Fred R. Miller, David H. Gorski
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1206.
https://doi.org/10.1158/1538-7445.AM2012-1206
Published: 15 April 2012
View article titled, Abstract 1206: Metabotropic glutamate receptor 1 functions as an oncogene in the progression of triple negative breast cancer
Journal Articles

Abstract 3950: The role of microRNA-130a in regulating HOXA5 expression in breast cancer progression

Malathi Banda, Cecilia L. Speyer, David H. Gorski
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3950.
https://doi.org/10.1158/1538-7445.AM2011-3950
Published: 15 April 2011
View article titled, Abstract 3950: The role of microRNA-130a in regulating HOXA5 expression in breast cancer progression
Journal Articles

Abstract 1673: mGluR1 as a potential therapeutic target in the treatment of triple negative breast cancer

Cecilia L. Speyer, Jennifer S. Smith, Malathi Banda, Tassia Mekani, David H. Gorski
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1673.
https://doi.org/10.1158/1538-7445.AM2011-1673
Published: 15 April 2011
View article titled, Abstract 1673: mGluR1 as a potential therapeutic target in the treatment of triple negative breast cancer
Journal Articles

Abstract 1578: The role of metabotropic glutamate receptor-1 in breast cancer tumor progression

Cecilia L. Speyer, Jennifer Smith, Malathi Banda, David H. Gorski
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1578.
https://doi.org/10.1158/1538-7445.AM10-1578
Published: 15 April 2010
View article titled, Abstract 1578: The role of metabotropic glutamate receptor-1 in breast cancer tumor progression